Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Anti-Cancer Drugs|January 31, 2017
Chemotherapy for localized head and neck squamous cell cancersAndy Karabajakian, Philippe Toussaint, Eve-Marie Neidhardt, et al.
Anti-Cancer Drugs|February 7, 2017
Chemotherapy for recurrent/metastatic head and neck cancersAndy Karabajakian, Philippe Toussaint, Eve-Marie Neidhardt, et al.
Bulletin Du Cancer|June 19, 2021
[New therapeutic strategies in HER2-positive breast cancer]Benoîte Mery, Philippe Toussaint, Pierre-Etienne Heudel, et al.
Bulletin Du Cancer|December 31, 2021
Benoîte Mery, Philippe Toussaint, Pierre-Etienne Heudel, et al.
European Journal of Cancer (Oxford, England : 1990)|September 17, 2025
Compression therapy with surgical gloves compared to cold therapy with frozen gloves in preventing paclitaxel-induced peripheral neuropathy: Results from the prospective ELEGANT trial in patients with breast cancerBrunhilde Hanvic, Aurélia Joureau-Chabert, Yaëlle Ouldbey, et al.
JMIR Cancer|May 18, 2023
A Digital Solution for an Advanced Breast Tumor Board: Pilot Application Cocreation and Implementation StudyKhalil Hodroj, David Pellegrin, Cindy Menard, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|January 29, 2025
Mucinous ovarian carcinoma: Impact of ovarian stimulation, hormonal contraception, and hormone replacement therapyChloé Barbier de Reulle, Marine Rebotier, Nicolas Chopin, et al.
Frontiers in Pharmacology|October 7, 2021
Real-World Experience of Bevacizumab as First-Line Treatment for Ovarian Cancer: The GINECO ENCOURAGE Cohort of 468 French PatientsDominique Berton, Anne Floquet, Willy Lescaut, et al.
Anticancer Research|January 25, 2023
Real-World Data on Olaparib in Relapsed BRCA-mutated Ovarian Cancer: A Multicenter GINECO RETROLA Cohort StudyHeloïse Bourien, Leïla Bengrine Lefevre, Marie-Ange Mouret-Reynier, et al.
Breast (Edinburgh, Scotland)|November 28, 2025
Nivolumab in combination with ipilimumab versus capecitabine as post-operative treatment for triple negative breast cancer patients with residual disease after neoadjuvant chemotherapy: a multicentre, randomized, open-label phase II trial - BREASTIMMUNE-03Olivier Trédan, Delphine Loirat, Sylvie Chabaud, et al.
Pageof 2